Heat shock protein 90 modulates the unfolded protein response by stabilizing IRE1alpha.
The molecular chaperone HSP90 regulates stability and function of multiple protein kinases. The HSP90-binding drug geldanamycin interferes with this activity and promotes proteasome-dependent degradation of most HSP90 client proteins. Geldanamycin also binds to GRP94, the HSP90 paralog located in the endoplasmic reticulum (ER). Because two of three ER stress sensors are transmembrane kinases, namely IRE1alpha and PERK, we investigated whether HSP90 is necessary for the stability and function of these proteins. We found that HSP90 associates with the cytoplasmic domains of both kinases. Both geldanamycin and the HSP90-specific inhibitor, 514, led to the dissociation of HSP90 from the kinases and a concomitant turnover of newly synthesized and existing pools of these proteins, demonstrating that the continued association of HSP90 with the kinases was required to maintain their stability. Further, the previously reported ability of geldanamycin to stimulate ER stress-dependent transcription apparently depends on its interaction with GRP94, not HSP90, since geldanamycin but not 514 led to up-regulation of BiP. However, this effect is eventually superseded by HSP90-dependent destabilization of unfolded protein response signaling. These data establish a role for HSP90 in the cellular transcriptional response to ER stress and demonstrate that chaperone systems on both sides of the ER membrane serve to integrate this signal transduction cascade.
Marcu
Monica G
MG
Cell and Cancer Biology Branch, National Cancer Institute, National Institutes of Health, Rockville, Maryland 20850, USA.
Doyle
Melissa
M
Bertolotti
Anne
A
Ron
David
D
Hendershot
Linda
L
Neckers
Len
L
D051702:Activating Transcription Factor 6; D000818:Animals; D000900:Anti-Bacterial Agents / Q000378:metabolism; D016227:Benzoquinones; D002460:Cell Line; D004268:DNA-Binding Proteins / Q000378:metabolism; D004721:Endoplasmic Reticulum / Q000378:metabolism*; D004722:Endoribonucleases / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000378:metabolism; D017930:Genes, Reporter; D018841:HSP90 Heat-Shock Proteins / Q000378:metabolism*; D006801:Humans; D007527:Isoenzymes / Q000235:genetics / Q000378:metabolism; D047029:Lactams, Macrocyclic; D008565:Membrane Proteins / Q000378:metabolism*; D018832:Molecular Chaperones / Q000378:metabolism*; D011485:Protein Binding; D017510:Protein Folding; D017346:Protein Serine-Threonine Kinases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D011809:Quinones / Q000737:chemistry / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000378:metabolism; D017828:Rifabutin / Q000378:metabolism; D015398:Signal Transduction / Q000502:physiology*; D019284:Thapsigargin / Q000378:metabolism; D014157:Transcription Factors / Q000378:metabolism; D019892:eIF-2 Kinase / Q000378:metabolism
D051702:Activating Transcription Factor 6; D000900:Anti-Bacterial Agents; D016227:Benzoquinones; D004268:DNA-Binding Proteins; D004722:Endoribonucleases; D004791:Enzyme Inhibitors; D018841:HSP90 Heat-Shock Proteins; D007527:Isoenzymes; D047029:Lactams, Macrocyclic; D008565:Membrane Proteins; D018832:Molecular Chaperones; D017346:Protein Serine-Threonine Kinases; D011809:Quinones; D011993:Recombinant Fusion Proteins; D017828:Rifabutin; D019284:Thapsigargin; D014157:Transcription Factors; D019892:eIF-2 Kinase; C497111:ATF6 protein, human; C403982:ERN2 protein, human; C001277:geldanamycin